Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study

BACKGROUND: Prophylactic transarterial chemoembolization (p-TACE) is strongly recommended for hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI), but the potential beneficiaries remain controversial. METHODS: Data of HCC patients with MVI who underwent R0 resection between Dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Ke, Qiao, Lin, Kongying, Chen, Jingbo, Wang, Ren, Xiao, Chunhong, Liu, Xiaolong, Liu, Jingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250178/
https://www.ncbi.nlm.nih.gov/pubmed/32547217
http://dx.doi.org/10.2147/CMAR.S251605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250178/
https://www.ncbi.nlm.nih.gov/pubmed/32547217
http://dx.doi.org/10.2147/CMAR.S251605

Ejemplares similares